BioPharma Resources

Drug Trial Radar · NCT07177339

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study of the Efficacy and Safety of Early Depemokimab Initiation as add-on Treatment in COPD Patients With Type 2 Inflammation

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,196 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,196

Planned (sponsor's estimate)

Start

Oct 20, 2025

Primary completion

Apr 2, 2029

Study completion Jun 4, 2029

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Sep 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Depemokimab is being developed as a treatment for individuals with moderate to severe Chronic Obstructive Pulmonary Disorder (COPD). The aim of this study is to assess the efficacy and safety of early initiation of depemokimab as an add-on medicine in participants with moderate to severe COPD with type 2 inflammation.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

  • DepemokimabDrug

    Depemokimab will be administered.

  • PlaceboDrug

    Matching placebo will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized Rate of Moderate/Severe ExacerbationsTime frame: From Baseline Up to Week 156

Locations

293 sites in 25 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Sheffield, Alabama · Recruiting

  • GSK Investigational Site

    Tucson, Arizona · Recruiting

  • GSK Investigational Site

    Escondido, California · Recruiting

  • GSK Investigational Site

    Long Beach, California · Recruiting

  • GSK Investigational Site

    Newport Beach, California · Recruiting

  • GSK Investigational Site

    San Jose, California · Recruiting

  • GSK Investigational Site

    Lakewood, Colorado · Recruiting

  • GSK Investigational Site

    Altamonte Springs, Florida · Recruiting

  • GSK Investigational Site

    Brandon, Florida · Recruiting

  • GSK Investigational Site

    Crystal River, Florida · Recruiting

  • GSK Investigational Site

    Doral, Florida · Recruiting

  • GSK Investigational Site

    Greenacres City, Florida · Recruiting

  • GSK Investigational Site

    Hialeah, Florida · Recruiting

  • GSK Investigational Site

    Hialeah, Florida · Recruiting

  • GSK Investigational Site

    Hollywood, Florida · Recruiting

  • GSK Investigational Site

    Loxahatchee Groves, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami Lakes, Florida · Recruiting

  • GSK Investigational Site

    Miami Lakes, Florida · Recruiting

  • GSK Investigational Site

    Naples, Florida · Recruiting

  • GSK Investigational Site

    Orlando, Florida · Recruiting

  • GSK Investigational Site

    Tampa, Florida · Recruiting

  • GSK Investigational Site

    Adairsville, Georgia · Recruiting

  • GSK Investigational Site

    Cordele, Georgia · Recruiting

  • GSK Investigational Site

    Dunwoody, Georgia · Recruiting

  • GSK Investigational Site

    Boise, Idaho · Recruiting

  • GSK Investigational Site

    Peoria, Illinois · Recruiting

  • GSK Investigational Site

    Indianapolis, Indiana · Recruiting

  • GSK Investigational Site

    Bowling Green, Kentucky · Recruiting

  • GSK Investigational Site

    Baton Rouge, Louisiana · Recruiting

  • GSK Investigational Site

    Lake Charles, Louisiana · Recruiting

  • GSK Investigational Site

    Metairie, Louisiana · Recruiting

  • GSK Investigational Site

    Shreveport, Louisiana · Recruiting

  • GSK Investigational Site

    Bangor, Maine · Recruiting

  • GSK Investigational Site

    Fall River, Massachusetts · Recruiting

  • GSK Investigational Site

    Allen Park, Michigan · Recruiting

  • GSK Investigational Site

    Clarkston, Michigan · Recruiting

Showing 40 of 293 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.